Watchlist Price Alert

VYNE Therapeutics Inc. (VYNE)

NASDAQ: VYNE · Real-Time Price · USD

0.93

0.02 (2.09%)

At close: Jun 17, 2025, 3:27 PM

VYNE Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-39.83M	-28.45M	-23.21M	-73.33M	-255.57M	-73.7M	-51.45M	-29.08M	-14.07M
Depreciation & Amortization	4K	n/a	72K	109K	341K	700K	22K	8K	4K
Stock-Based Compensation	3.3M	3.31M	4.3M	8.08M	18.1M	6.7M	3.64M	1.45M	573K
Other Working Capital	-114K	214K	-349K	-371K	-4.17M	1.41M	-8.55M	-1.74M	10.18M
Other Non-Cash Items	-2.44M	-254K	-12.64M	2.47M	84.07M	-691K	-774K	31K	705K
Deferred Income Tax	n/a	n/a	n/a	1.52M	56.3M	n/a	n/a	60K	-573K
Change in Working Capital	5M	60K	2.28M	4.78M	-40.33M	1.89M	-4.17M	-722K	11.07M
Operating Cash Flow	-33.97M	-25.34M	-29.2M	-56.37M	-137.08M	-65.1M	-52.73M	-28.25M	-2.29M
Capital Expenditures	-117K	n/a	n/a	n/a	-113K	-11K	-140K	-27K	-31K
Cash Acquisitions	n/a	5M	15.67M	n/a	38.64M	40K	n/a	-25K	n/a
Purchase of Investments	-60.52M	-62.35M	n/a	n/a	-38.64M	-83.4M	-126.7M	-64.15M	-55.31M
Sales Maturities Of Investments	84M	n/a	n/a	1.03M	50.58M	124.78M	92.96M	49.11M	17.85M
Other Investing Acitivies	n/a	n/a	15.67M	n/a	38.64M	-40K	n/a	25K	n/a
Investing Cash Flow	23.36M	-57.35M	15.67M	1.03M	89.11M	41.37M	-33.88M	-15.06M	-37.49M
Debt Repayment	n/a	n/a	n/a	-36.43M	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	-360K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-141K	-67K	-28K	228K	169K	465K	496K	-833K	n/a
Financial Cash Flow	-141K	82.39M	1.65M	39.78M	61.81M	4.99M	125.91M	49.49M	n/a
Net Cash Flow	-10.75M	-301K	-11.88M	-15.56M	13.83M	-18.73M	39.3M	6.18M	-39.78M
Free Cash Flow	-34.09M	-25.34M	-29.2M	-56.37M	-137.19M	-65.11M	-52.87M	-28.27M	-2.32M